CompanyGraph
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $6.68B, above the global median of $1.14B
- PositionP/E ratio is 455.27×, higher than 95% of its Diagnostics & Research peers (median 38.1×)
- Interpretations1 currently firing — 1
What this company is and how it runs — written from structure, not news.
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.24%Below 5Y avg (0.52%)
Annual Rate
CNY 0.13Paid annual
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jul 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
44.60BCNY6.68B · vs all stocks (USD)
Trailing P/E
455.27xvs Diagnostics & Research peers
Revenue (TTM)
7.29BCNY1.09B · vs all stocks (USD)
Profit Margin
1.25%vs Diagnostics & Research peers
Beta
0.4330xvs all stocks
52-Week Change
-2.67%vs all stocks
Market Capitalization
44.60BCNY6.68B · vs all stocks (USD)
Enterprise Value
49.09BCNY7.35B · vs all stocks (USD)
Trailing P/E
455.27xvs Diagnostics & Research peers
Forward P/E
40.72xvs Diagnostics & Research peers
Price to Sales (TTM)
5.92xvs Diagnostics & Research peers
Price to Book (MRQ)
2.32xvs Diagnostics & Research peers
Enterprise to Revenue
6.73xvs Diagnostics & Research peers
Enterprise to EBITDA
56.69xvs Diagnostics & Research peers
Gross Margin
28.36%vs Diagnostics & Research peers
Profit Margin
1.25%vs Diagnostics & Research peers
Operating Margin
11.83%vs Diagnostics & Research peers
Return on Assets (TTM)
1.43%vs Diagnostics & Research peers
Return on Equity (TTM)
1.09%vs Diagnostics & Research peers
Revenue (TTM)
7.29BCNY1.09B · vs all stocks (USD)
Revenue per Share (TTM)
8.47CNYUpdated Oct 21, 2026Quarterly Revenue Growth
13.00%vs Diagnostics & Research peers
Gross Profit (TTM)
1.92BCNY286.82M · vs all stocks (USD)
EBITDA (TTM)
1.62BCNY242.35M · vs all stocks (USD)
Net Income (TTM)
91.39MCNY13.68M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
21.86%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
1.14BCNY169.97M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
948.97MCNY142.08M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1260CNYUpdated Oct 21, 2026Trailing Annual Dividend Yield
0.24%vs all stocks
5-Year Average Dividend Yield
0.52%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Minority Interest (Equity)
3.30BCNYFY2025 · Dec 31, 2025Revenue
6.83BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.96BCNYFY2025 · Dec 31, 2025Gross Profit
1.87BCNYFY2025 · Dec 31, 2025Operating Income
666.64MCNY99.81M · vs all stocks (USD)
Pre-tax Income
1.00BCNYFY2025 · Dec 31, 2025Income Tax Expense
198.16MCNYFY2025 · Dec 31, 2025Net Income
805.06MCNYFY2025 · Dec 31, 2025EBIT
1.09BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.41BCNYFY2025 · Dec 31, 2025Research & Development
257.64MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
322.20MCNYFY2025 · Dec 31, 2025Other Operating Expenses
34.93MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
15.13MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
90.56MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.04CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.04CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
853.74MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
853.74MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
805.06MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
82.83MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
697.84MCNYFY2025 · Dec 31, 2025Free Cash Flow
489.40MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.72BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
805.06MCNYFY2025 · Dec 31, 2025Other Non-cash Items
150.32MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-199.80MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-57.73MCNYFY2025 · Dec 31, 2025Capital Expenditures
-208.44MCNYFY2025 · Dec 31, 2025Net Acquisitions
-164.95MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.92BCNYFY2025 · Dec 31, 2025Sale of Investments
2.83BCNYFY2025 · Dec 31, 2025Other Investing Activity
-49.19MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
491.56MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.14BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.37BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-343.66MCNYFY2025 · Dec 31, 2025Other Financing Charges
-347.19MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.93BCNYFY2025 · Dec 31, 2025Shares Outstanding
861.03MSharesUpdated Oct 21, 2026Float Shares
646.02MSharesUpdated Oct 21, 2026% Held by Insiders
32.27%vs all stocks
% Held by Institutions
31.74%vs all stocks
Total Cash (MRQ)
2.14BCNY320.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.37CNYUpdated Oct 21, 2026Total Debt (MRQ)
2.34BCNY350.91M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1015xvs Diagnostics & Research peers
Current Ratio (MRQ)
2.49xvs Diagnostics & Research peers
Book Value per Share (MRQ)
21.54CNYUpdated Oct 21, 2026Total Assets
28.36BCNY4.25B · vs all stocks (USD)
Total Current Assets
6.18BCNYFY2025 · Dec 31, 2025Total Liabilities
4.10BCNYFY2025 · Dec 31, 2025Total Non-current Assets
22.18BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.27BCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.84BCNYFY2025 · Dec 31, 2025Cash
1.71BCNYFY2025 · Dec 31, 2025Cash Equivalents
67.91MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.78BCNYFY2025 · Dec 31, 2025Other Short-term Investments
59.46MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.41BCNYFY2025 · Dec 31, 2025Inventory
41.50MCNYFY2025 · Dec 31, 2025Accounts Payable
371.12MCNYFY2025 · Dec 31, 2025Short-term Debt
712.55MCNYFY2025 · Dec 31, 2025Other Current Liabilities
38.79MCNYFY2025 · Dec 31, 2025Long-term Debt
963.65MCNYFY2025 · Dec 31, 2025Common Stock (Book)
861.03MCNYFY2025 · Dec 31, 2025Retained Earnings
9.32BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
24.26BCNY3.63B · vs all stocks (USD)
Treasury Stock
300.07MCNYFY2025 · Dec 31, 202552-Week Low
35.57CNYUpdated Oct 21, 202652-Week High
67.85CNYUpdated Oct 21, 202652-Week Change
-2.67%vs all stocks
Beta
0.4330xvs all stocks
50-Day MA
54.59CNYUpdated Oct 21, 2026200-Day MA
53.04CNYUpdated Oct 21, 2026Avg 10-Day Volume
10.35MSharesUpdated Oct 21, 2026Avg 30-Day Volume
12.85MSharesUpdated Oct 21, 2026Diluted EPS (TTM)
0.1100CNYUpdated Oct 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 455.27×, higher than 95% of its Diagnostics & Research peers (median 38.1×)Significant
P/E ratio: 455.273Industry median: 38.10Industry P95: 234.059Peers compared: 28.00
Structural Tensions
Most companies in its industry are production businesses; this one is a sense-making businessSignificant
Industry peers: 69.00Share on the common pattern %: 97.00
Financial Health
Altman Z-Score 7.49: safe zoneNotable
Altman Z-Score: 7.49
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $6.68B, above the global median of $1.14BNotable
Market cap (USD): 6,677,684,086.671Global Median: 1,138,450,684.034
Revenue is $1.09B, above the global median of $562.3MNotable
Revenue (USD): 1,091,446,285.804Global Median: 562,304,852.367
Levered free cash flow is $142.08M, above the global median of $18.69MNotable
Levered free cash flow (USD): 142,079,546.452Global Median: 18,689,872.41
Companies that share the same coordination system — how they create, deliver, or capture value.
Primarius Technologies Co. Ltd.
Tier 1SenseMakingThroughput-Bound ConversionProductionInterface
Medpace Holdings Inc.
Tier 1SenseMakingThroughput-Bound ConversionFlowRule
Merit Interactive Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceProduction
Chengdu Yunda Technology Co. Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceFlow
JC Finance & Tax Interconnect Co. Ltd.
Tier 1SenseMakingThroughput-Bound ConversionFlowRule
Digital China Holdings Limited
Tier 1SenseMakingThroughput-Bound ConversionInterfaceProduction
Hefei Taihe Intelligent Technology Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceProduction
Great Chinasoft Technology Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceFlow
Wuhan Kotei Informatics Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionProductionFlow
Materials Analysis Technology Inc.
Tier 1SenseMakingThroughput-Bound ConversionProductionRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Card Factory plc
1 interpretationWorking Capital Pattern
China Merchants Port Group Co. Ltd.
1 interpretationWorking Capital Pattern
Chipotle Mexican Grill, Inc.
1 interpretationWorking Capital Pattern